Skip to main content
Have a personal or library account? Click to login
Secondary prevention of patients with ischaemic stroke after recanalization treatment Cover

Secondary prevention of patients with ischaemic stroke after recanalization treatment

European Pharmaceutical Journal
Volume 69 (2022): Issue s1 (July 2022)
By: ,  ,   and    
Open Access
|Jul 2022
Figures & tables

Figures & Tables

Figure 1

Average values of National Institute of Health Stroke Scale - NIHSS.

Figure 2

Important time attributes.

Figure 3

Pharmacotherapy, NSAIDS nonsteroidal antiinflammatory drugs, *p≤0.05.

Figure 4

Antithrombotic therapy ASA - acetylasalicylic acid, NOACs - new oral anticoagulants.

DOI: https://doi.org/10.2478/afpuc-2022-0013 | Journal eISSN: 2453-6725 (formerly 1338-6786) | Journal ISSN: 0301-2298
Journal RSS Feed
Language: English
Page range: 79 - 81
Submitted on: Jun 4, 2022
Accepted on: Jun 6, 2022
Published on: Jul 13, 2022
Published by: Comenius University in Bratislava, Faculty of Pharmacy
In partnership with: Paradigm Publishing Services
Keywords:
ischaemic stroke,
secondary prevention,
antiplatelet therapy,
anticoagulant therapy,
intravenous thrombolysis
Related subjects:
Pharmacy,
Pharmacy, other

© 2022 Michaela Benesová, Marek Krivošík, Stanislava Kosírová, Tatiana Foltánová, published by Comenius University in Bratislava, Faculty of Pharmacy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 69 (2022): Issue s1 (July 2022)
Previous article
Next article